Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Wagner Charles F Jr
Relationship:   EVP & Chief Financial ...
City:   Billerica
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   234,683    

Indirect Shares

   0      
Direct Value   $33,475,448    

Indirect Value

   $0      
Total Shares   234,683      
Total Value   $33,475,448      


Progress Software Corp $4,086,350 Bruker Corp $8,090,927 Vertex Pharmaceuticals Inc $21,298,171 Progress Software Corp $4,086,350 Bruker Corp $8,090,927 Vertex Pharmaceuticals Inc $21,298,171
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Progress Software Corp PRGS EVP Finance & Admin an... 2011-10-14 81,175 0    Premium*  
            Bruker Corp BRKR EVP & Chief Financial ... 2015-03-17 99,925 2012-08-02 0    Premium*  
            Vertex Pharmaceuticals Inc VRTX EVP & Chief Financial ... 2024-02-23 53,583 2019-04-10 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2024-02-23 4 D $431.79 $1,428,793 D/D (3,309) 53,583 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2024-02-20 4 D $420.58 $1,182,671 D/D (2,812) 56,892 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2024-02-16 4 D $424.01 $1,590,038 D/D (3,750) 59,704 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2024-02-09 4 D $422.74 $1,102,083 D/D (2,607) 63,454 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2024-02-07 4 A $0.00 $0 D/D 7,114 66,061 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2024-02-06 4 A $0.00 $0 D/D 15,254 58,947 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2024-01-02 4 AS $405.00 $1,215,000 D/D (3,000) 43,693 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-11-20 4 AS $349.88 $1,049,640 D/D (3,000) 46,693 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-03-24 4 AS $305.38 $539,912 D/D (1,768) 49,611 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-03-17 4 AS $294.52 $592,786 D/D (2,000) 51,379 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-03-13 4 AS $288.31 $783,346 D/D (2,666) 53,379 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-03-10 4 AS $286.64 $604,709 D/D (2,088) 56,045 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-02-24 4 D $289.12 $956,409 D/D (3,308) 58,133 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-02-17 4 D $292.85 $1,098,188 D/D (3,750) 61,441 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-02-13 4 D $298.26 $1,488,914 D/D (4,992) 65,191 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-02-10 4 D $294.33 $796,751 D/D (2,707) 70,183 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-02-01 4 A $0.00 $0 D/D 30,026 72,890 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-05-02 4 AS $254.87 $88,778 D/D (343) 42,730 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-04-29 4 D $276.17 $151,065 D/D (547) 43,073 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-04-01 4 AS $261.42 $683,602 D/D (2,582) 43,620 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-03-17 4 AS $250.13 $793,218 D/D (3,171) 46,202 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-24 4 D $227.86 $498,786 D/D (2,189) 49,373 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-17 4 D $232.51 $799,602 D/D (3,439) 51,562 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-10 4 D $237.74 $578,659 D/D (2,434) 55,001 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-02 4 AS $250.07 $736,206 D/D (2,944) 57,435 0 %
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us